Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M4BB
|
||||
Former ID |
DIB013594
|
||||
Drug Name |
Chi Lob 7/4
|
||||
Synonyms |
Anti-CD40 MAb (chimeric, cancer), Cancer Research UK
|
||||
Indication | B-cell lymphoma [ICD9: 202.8; ICD10:C85.1] | Phase 1 | [523848] | ||
Company |
Cancer Research UK
|
||||
Target and Pathway | |||||
Target(s) | Tumor necrosis factor ligand superfamily member 5 | Target Info | Modulator | ||
KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
NF-kappa B signaling pathway | |||||
Cell adhesion molecules (CAMs) | |||||
T cell receptor signaling pathway | |||||
Intestinal immune network for IgA production | |||||
Malaria | |||||
Toxoplasmosis | |||||
Asthma | |||||
Autoimmune thyroid disease | |||||
Systemic lupus erythematosus | |||||
Allograft rejection | |||||
Primary immunodeficiency | |||||
Viral myocarditis | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.